A Geneticist’s Quest to Understand His Son’s Mysterious Disease

Ronald Davis of Stanford University changed his focus to research on ME/CFS, the disease formerly known as chronic fatigue syndrome, in a bid to help his son and others like him.

Written byTracie White
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, ILEXX

About 10 years ago, Stanford University genomicist Ronald W. Davis began a new investigation into a mysterious disease that had disabled his son, Whitney Dafoe. A photographer and avid traveller in his 20s, Dafoe could no longer care for himself. He slowly lost the ability to eat and eventually even to speak. He visited doctors for years before he finally found one who could diagnose him with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) based on his strange constellation of symptoms. But with the diagnosis, Dafoe and his family soon learned that little research had been done on the disease, and there was no treatment. Davis decided to do what he could to fill that gap.

Davis’s first step was to set up a centrifuge in the tool shed in his backyard. When he got home from his job as director of the Stanford Genome Technology Center, he’d ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • The Scientist Placeholder Image
    Tracie White is an award-winning journalist and a science writer for Stanford Medicine. She graduated from UC Berkley and has a master's degree in journalism from Northwestern University. She lives in Aptos, California.View Full Profile

Published In

January 2021

Expecting and Infected

What science is revealing about COVID-19 in mothers to be

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies